The development of analytical strategies enabling the chiral separation of ketorolac by electrokinetic chromatography is presented in this work. This anti-inflammatory drug is commercialised as racemic mixture but its physiological activity resides in the S-enantiomer. Different experimental conditions were investigated at acidic and neutral pH, including the use of cyclodextrins (CD) or amino acid-based ionic liquids (AAILs) ([TMA][L-Cit], [TMA][L-Arg], [TMA][L-Harg], [TBA][L-Cit], [TBA][L-Arg], and [TBA][L-Harg]) as the sole chiral selectors or the combination of a CD with AAILs or their cationic components (tetramethylammonium (TMA-OH) or tetrabutylammonium (TBA-OH)). The best conditions in terms of migration times and enantiomeric resolutions were obtained using 2 mM heptakis(2,3,6-tri-O-methyl)-β-CD (TM-β-CD) in 50 mM phosphate buffer at pH 7.0 or 2 mM TM-β-CD with 60 mM TMA-OH in 50 mM formate buffer at pH 3.0. The presence of TMA-OH in the separation medium affected considerably the electroosmotic flow (EOF) mobility which, in turn, significantly shortened the migration times for ketorolac enantiomers at pH 3.0 due to an inversion in the EOF. The multivariate optimization of the experimental conditions for the single system and for the combined system with TMA-OH enabled to obtain the separation of ketorolac enantiomers in less than 11 min with enantiomeric resolutions of 2.5 and 1.9, respectively. The single system was selected to evaluate its analytical characteristics in terms of limits of detection/quantification, accuracy, and precision, according to the International Council for Harmonization (ICH) guidelines, which resulted adequate to be applied to the analysis of pharmaceutical formulations.
Read full abstract